# Amgen Inc. (AMGN) — Q4-2021 Earnings Results

**Report date:** 2022-02-07 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2021

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.64%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.36 | N/A | +5.29% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their current strategies and emphasized the importance of their product pipeline. They remain focused on delivering value to patients and shareholders.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in innovation and pipeline development.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock's slight increase of 0.64% reflects investor confidence in the company's performance and future prospects, despite the lack of revenue data and guidance. The management's focus on innovation and pipeline development suggests a commitment to long-term growth.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2021_